Bionik Laboratories Corp. Annual Nonoperating Income (Expense) in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bionik Laboratories Corp. annual/quarterly Nonoperating Income (Expense) history and growth rate from 2021 to 2022.
  • Bionik Laboratories Corp. Nonoperating Income (Expense) for the quarter ending December 31, 2022 was -$32.8K, a 87.2% increase year-over-year.
  • Bionik Laboratories Corp. annual Nonoperating Income (Expense) for 2022 was -$121K, a 72.2% increase from 2021.
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$121K +$314K +72.2% Apr 1, 2022 Mar 31, 2023 10-K 2023-06-21
2021 -$435K Apr 1, 2021 Mar 31, 2022 10-K 2023-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.